Department of Emergency Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Ebba Lunds Vej 40A, Entrance 67, 2400 NV, Copenhagen, Denmark.
Department of Emergency Medicine, Slagelse Hospital, Slagelse, Denmark.
BMC Infect Dis. 2021 Apr 1;21(1):315. doi: 10.1186/s12879-021-06007-9.
The primary objective of our study was to examine predictors for readmission in a prospective cohort of sepsis patients admitted to an emergency department (ED) and identified by the new Sepsis-3 criteria.
A single-center observational population-based cohort study among all adult (≥18 years) patients with sepsis admitted to the emergency department of Slagelse Hospital during 1.10.2017-31.03.2018. Sepsis was defined as an increase in the sequential organ failure assessment (SOFA) score of ≥2. The primary outcome was 90-day readmission. We followed patients from the date of discharge from the index admission until the end of the follow-up period or until the time of readmission to hospital, emigration or death, whichever came first. We used competing-risks regression to estimate adjusted subhazard ratios (aSHRs) with 95% confidence intervals (CI) for covariates in the regression models.
A total of 2110 patients were admitted with infections, whereas 714 (33.8%) suffered sepsis. A total of 52 patients had died during admission and were excluded leaving 662 patients (44.1% female) with a median age of 74.8 (interquartile range: 66.0-84.2) years for further analysis. A total of 237 (35,8%; 95% CI 32.1-39.6) patients were readmitted within 90 days, and 54(8.2%) had died after discharge without being readmitted. We found that a history of malignant disease (aSHR 1,61; 1.16-2.23), if previously admitted with sepsis within 1 year before the index admission (aSHR; 1.41; 1.08-1.84), and treatment with diuretics (aSHR 1.51; 1.17-1.94) were independent predictors for readmission. aSHR (1.49, 1.13-1.96) for diuretic treatment was almost unchanged after exclusion of patients with heart failure, while aSHR (1.47, 0.96-2.25) for malignant disease was slightly attenuated after exclusion of patients with metastatic tumors.
More than one third of patients admitted with sepsis, and discharged alive, were readmitted within 90 days. A history of malignant disease, if previously admitted with sepsis, and diuretic treatment were independent predictors for 90-day readmission.
本研究的主要目的是通过新的 Sepsis-3 标准,在一个因败血症入住急诊科并被识别的败血症患者前瞻性队列中,检验再入院的预测因素。
这是一项单中心观察性基于人群的队列研究,纳入了 2017 年 10 月 1 日至 2018 年 3 月 31 日期间因败血症入住斯劳厄尔瑟医院急诊科的所有成年(≥18 岁)患者。败血症的定义为序贯器官衰竭评估(SOFA)评分增加≥2 分。主要结局是 90 天再入院。我们从指数入院出院日期开始随访患者,直到随访期结束或患者再次入院、移民或死亡,以先发生者为准。我们使用竞争风险回归来估计回归模型中协变量的调整后亚危险比(aSHR)及其 95%置信区间(CI)。
共有 2110 名患者因感染入院,其中 714 名(33.8%)患有败血症。共有 52 名患者在住院期间死亡,被排除在外,留下 662 名(44.1%为女性)患者进一步分析,中位年龄为 74.8(四分位距:66.0-84.2)岁。共有 237 名(35.8%;95%CI 32.1-39.6)患者在 90 天内再次入院,54 名(8.2%)患者出院后未再入院但已死亡。我们发现,恶性肿瘤病史(aSHR 1.61;1.16-2.23)、在指数入院前 1 年内曾因败血症入院(aSHR;1.41;1.08-1.84)以及利尿剂治疗(aSHR 1.51;1.17-1.94)是再入院的独立预测因素。排除心力衰竭患者后,利尿剂治疗的 aSHR(1.49,1.13-1.96)几乎不变,而排除转移性肿瘤患者后,恶性肿瘤病史的 aSHR(1.47,0.96-2.25)略有减弱。
超过三分之一因败血症入院并存活出院的患者在 90 天内再次入院。恶性肿瘤病史、曾因败血症入院和利尿剂治疗是 90 天再入院的独立预测因素。